N-(4-bromo-3-methoxyphenyl)-6-nitroquinazolin-4-amine (2f)
.
N-(2,4-dimethoxyphenyl)-6-nitroquinazolin-4-amine (2g

N-(2-ethylphenyl)-6-nitroquinazolin-4-amine (2h)
N-(3-ethylphenyl)-6-nitroquinazolin-4-amine (2i
4-((6-nitroquinazolin-4-yl)amino)benzenesulfonamide (2k
4-((6-nitroquinazolin-4-yl)amino)-N-(thiazol-2-yl)benzenesulfonamide (2m
4-((6-nitroquinazolin-4-yl)amino)-N-(pyridin-2-yl)benzenesulfonamide (2n
4-((6-aminoquinazolin-4-yl)amino)benzenesulfonamide (3k
4-((6-aminoquinazolin-4-yl)amino)-N-carbamimidoylbenzenesulfonamide (3l
4-((6-aminoquinazolin-4-yl)amino)-N-(thiazol-2-yl)benzenesulfonamide (3m
4-((6-aminoquinazolin-4-yl)amino)-N-(pyridin-2-yl)benzenesulfonamide (3n
General procedure for the synthesis of compounds (4a-4j, 4o).
A mixture of the corresponding aminoquinazoline derivative 3a-3j, 3o (1 mmol) and NaHCO 3 (1.3 mmol) was stirred at 0°C in acetone (10 ml) under nitrogen atmosphere. This is then followed by dropwise addition of acryloyl chloride (1.3 mmol) and then was stirred for 30 min. at 0°C. Excess solvent was then removed under reduced pressure and the remaining residue was neutralized using NaHCO 3 solution. The formed solid was then filtered and the purified using column chromatography with ethylacetate as eluent.
General procedure for the synthesis of compounds (4k-4n).
Same above procedure except that the solvent used in the reaction was DMF instead of acetone and the eluent in column chromatography was Dichloromethane:Methanol 100:5. 
N-(4-
(
Hz). LC/MS (+ESI): m/z = 323.18 (M + H).
N-(4-((4-bromo-3-methoxyphenyl)amino)quinazolin-6-yl)acrylamide (4f
N-(4-((2,4-dimethoxyphenyl)amino)quinazolin-6-yl)acrylamide (4g
N-(4-((4-ethylphenyl)amino)quinazolin-6-yl)acrylamide (4j
N-(4-((4-(N-carbamimidoylsulfamoyl)phenyl)amino)quinazolin-6-yl)acrylamide (4l).
Yield LC/MS (+ESI): m/z = 412.10 (M + H).
N-(4-((4-(N-(thiazol-2-yl)sulfamoyl)phenyl)amino)quinazolin-6-yl)acrylamide (4m).
Yield 60% (0.27 g, solid); m. (N-(pyridin-2-yl) 
N-(4-((4-
General procedure for the synthesis of compounds (8a-8f).
A mixture of 7 (3 mmol) and the corresponding amine (3.2 mmol) in 1ml ethanol was refluxed for 8 h. The reaction mixture was concentrated, and the residue was partitioned between water and dichloromethane; the organic layer separated, dried over anhydrous General procedure for the synthesis of compounds (9a-9f). General procedure for the synthesis of compounds (10a-10f).
A mixture of the corresponding intermediate 9a-9f (1 mmol) and NaHCO 3 (1.3 mmol)
was stirred at 0°C in acetone (10 ml) under nitrogen atmosphere. This is then followed by dropwise addition of acryloyl chloride (1.3 mmol) and then was stirred for 30 min. at 0°C. Excess solvent was then removed under reduced pressure and the remaining residue was neutralized using NaHCO 3 solution. The formed solid was then filtered and the purified using column chromatography using a mixture of dichloromethane:methanol (100:1) as eluent. values.
1-(4-
Growth Assay
SKBR3 and H1975 cells were treated with 8 concentrations of inhibitors ranging from 50 µM to 8 nM (specifially, the doses tested were 50uM, 25uM, 10uM, 5uM, 1uM, 0.2uM, 0.04uM, and 0.008uM) followed by EGF stimulation (100 ng/mL) 1 h later. Cells were incubated for an additional 72 h at 37°C. Relative cell growth was determined by addition of Promega CellTiter Glo luciferase-based measure of ATP content, and the resulting luminescence was measured using a Molecular Devices Spectramax Paradigm microplate reader in luminescence mode. Growth inhibition data were analyzed using DMSO as a baseline (negative control equal to 0% growth inhibition) with GraphPad Prism curve fitting software. IC50 values are representative of the results at least two independent concentration-response experiments with three replicates per concentration.
EGFR kinase phosphorylation assay
Phosphorylation assays were performed in a final volume of 20 µl containing 8 mM 
Molecular modeling
The proteins used for the docking was downloaded from the protein data bank (PDB 2J5F, 3W2P). The proteins were first prepared for docking using MOE software where the proteins were protonated and saved for docking. The ligands were drawn on MOE and energy minimized and then saved as "mol2" file. Docking was done using GOLD software, where the proteins are first prepared by removing the water molecules and extracting the co-crystallized ligands. The docking of the compounds included a covalent interaction which was done by specifying the atoms in the ligand and the protein that will covalently bind together and then docking was done using CHEMPLP as the scoring function and Goldscore as a rescoring function. The viewing of the results was done using PyMOL software and the side chains from the docked molecules were hidden to facilitate the viewing process.
